Nicolas Chuvin

1.2k total citations · 2 hit papers
10 papers, 521 citations indexed

About

Nicolas Chuvin is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Nicolas Chuvin has authored 10 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Nicolas Chuvin's work include Immunotherapy and Immune Responses (5 papers), vaccines and immunoinformatics approaches (3 papers) and CAR-T cell therapy research (3 papers). Nicolas Chuvin is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), vaccines and immunoinformatics approaches (3 papers) and CAR-T cell therapy research (3 papers). Nicolas Chuvin collaborates with scholars based in France, United Kingdom and United States. Nicolas Chuvin's co-authors include Stéphane Depil, Jenny Valladeau‐Guilemond, Audrey Page, Ulrich Valcourt, Sylvie Martel, Stéphanie Sentis, Laurent Bartholin, Lindsay B. Alcaraz, Roxane M. Pommier and Vincent Alcazer and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and Cancer Research.

In The Last Decade

Nicolas Chuvin

10 papers receiving 514 citations

Hit Papers

TCR-engineered T cell therapy in solid tumors: State of t... 2023 2026 2024 2025 2023 2024 50 100 150 200

Peers

Nicolas Chuvin
Jeongheon Yoon United States
Nicolas Chuvin
Citations per year, relative to Nicolas Chuvin Nicolas Chuvin (= 1×) peers Jeongheon Yoon

Countries citing papers authored by Nicolas Chuvin

Since Specialization
Citations

This map shows the geographic impact of Nicolas Chuvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Chuvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Chuvin more than expected).

Fields of papers citing papers by Nicolas Chuvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Chuvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Chuvin. The network helps show where Nicolas Chuvin may publish in the future.

Co-authorship network of co-authors of Nicolas Chuvin

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Chuvin. A scholar is included among the top collaborators of Nicolas Chuvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Chuvin. Nicolas Chuvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Page, Audrey, Nicolas Chuvin, Jenny Valladeau‐Guilemond, & Stéphane Depil. (2024). Development of NK cell-based cancer immunotherapies through receptor engineering. Cellular and Molecular Immunology. 21(4). 315–331. 100 indexed citations breakdown →
2.
Chuvin, Nicolas, et al.. (2023). TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. Science Advances. 9(7). eadf3700–eadf3700. 223 indexed citations breakdown →
3.
Alcazer, Vincent, Paola Bonaventura, Laurie Tonon, et al.. (2022). HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. American Journal of Hematology. 97(9). 1200–1214. 15 indexed citations
4.
5.
Bonaventura, Paola, Vincent Alcazer, Laurie Tonon, et al.. (2022). Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Science Advances. 8(4). eabj3671–eabj3671. 63 indexed citations
6.
Bonaventura, Paola, Vincent Alcazer, Laurie Tonon, et al.. (2021). 691 Identification of shared tumor epitopes from endogenous retroviruses inducing high avidity cytotoxic T cells for cancer immunotherapy. SHILAP Revista de lepidopterología. A719–A719. 8 indexed citations
7.
Cardot‐Ruffino, Victoire, Véronique Chauvet, Nicolas Chuvin, et al.. (2020). Generation of an Fsp1 (fibroblast‐specific protein 1)‐Flpo transgenic mouse strain. genesis. 58(5). e23359–e23359. 3 indexed citations
8.
Cardot‐Ruffino, Victoire, Véronique Chauvet, Nicolas Chuvin, et al.. (2020). Generation of a conditional Flpo/FRT mouse model expressing constitutively active TGFβ in fibroblasts. Scientific Reports. 10(1). 3880–3880. 3 indexed citations
9.
Pommier, Roxane M., Johann Gout, David F. Vincent, et al.. (2015). TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability. Cancer Research. 75(20). 4335–4350. 31 indexed citations
10.
Alcaraz, Lindsay B., Jean‐Yves Exposito, Nicolas Chuvin, et al.. (2014). Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β. The Journal of Cell Biology. 205(3). 409–428. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026